Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

7.7%

1 terminated/withdrawn out of 13 trials

Success Rate

91.7%

+5.2% vs industry average

Late-Stage Pipeline

46%

6 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4
6(66.7%)
N/A
3(33.3%)
9Total
Phase 4(6)
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT05069402Not ApplicableCompleted

Impact of Various Diets on Surgical Complications

Role: lead

NCT05068882Not ApplicableUnknown

Impact of Oral Diets on Postoperative Fluid Collection

Role: lead

NCT03980704Phase 4Completed

Preoperative High Protein vs Immunodiet in Surgical Cancer Patients

Role: lead

NCT04771832Completed

ERAS in Gastrointerstinal Fistulas.

Role: lead

NCT04467138Completed

High Dose Intravenous Fish Oil Reduces Inflammation

Role: lead

NCT04347902Phase 4Completed

Lipid Emulsions and Liver Function - Results After 5 Years.

Role: lead

NCT02653131Phase 4Terminated

The Use of DPP-4 Inhibitors in Short Bowel Syndrome

Role: lead

NCT02997267Not ApplicableCompleted

Early Closure of Protective Ileostomy in Rectal Cancer Patients

Role: lead

NCT01907347Completed

Prognosis Value of Bioimpedance Analysis (BIA) Phase Angle at Admission in Intensive Care Unit (ICU) Patients

Role: collaborator

NCT03044639Phase 4Completed

Parenteral Lipid Emulsions and the Liver Function

Role: lead

NCT02853539Phase 4Completed

Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients

Role: lead

NCT02122120Completed

The Value of Aritficial Diet and Complex Care in Home Nutrition

Role: lead

NCT02009189Phase 4Completed

Taurolidine Lock in Long Term Parenteral Nutrition

Role: lead

All 13 trials loaded